February 4, 2014 – (BRONX, NY) – When the foe is a disease-causing microbe, identifying the structure of its component proteins can greatly aid efforts to kill or disable it. Research to gain this knowledge will be bolstered by a $3 million grant from The Price Family Foundation. The gift to Albert Einstein College of Medicine of Yeshiva University and the University of Oklahoma funds a research collaboration to investigate the structural biology of the key proteins of anaerobic microorganisms (those that don't use oxygen).
The research consortium, led at Einstein by Vern Schramm, Ph.D., Steven Almo, Ph.D., and James Love, Ph.D., will focus specifically on Clostridium difficile, a notorious bacterial species that infects the intestinal tract and that the U.S. Centers for Disease Control and Prevention considers an "urgent" health threat.
Toxins produced by C. difficile can damage the lining of the colon, causing colitis. Each year in the U.S., infections with this microbe sicken at least 250,000 people and cause at least 14,000 deaths. The joint project is aimed at finding better treatments for C. difficile infections. It will capitalize on Einstein's expertise in structural biology and its high-throughput analytic capabilities along with OU's expertise in anaerobic microbiology and chemistry.
"Michael Price and his family have a long history of support to Einstein and biomedical research around the country," said Dr. Schramm, professor and chair of biochemistry and Ruth Merns Chair in Biochemistry at Einstein. "This new gift is an inspired way to leverage the unique talents and facilities at our two institutions to make a real advancement in an increasing danger to human health."
"This gift from the Price Family Foundation will put OU researchers in a leading role in this important area of research dealing with the impact of protein," said OU President David L. Boren. "It will further our partnership with Einstein in this area."
A Legacy of Support Mr. Price joined Einstein's Board of Overseers in 2001 and is the former chair of its executive committee. The Price Family Foundation is a generous donor to both Einstein and OU. In 2001, they made what was at the time the largest commitment in Einstein's history: $25 million to help establish the College of Medicine's state-of-the-art center for genetic and translational research. The Michael F. Price Center for Genetic and Translational Medicine/Harold and Muriel Block Research Pavilion officially opened in 2008.
In 2011, the Price Family Foundation made a significant contribution toward consolidating Einstein's Children's Evaluation and Rehabilitation Center's clinical and research units within newly renovated quarters of the Van Etten Building. They have also made a commitment of $2.5 million to help establish the Center for Experimental Therapeutics at Einstein.
The Price Family Foundation is also a long-term supporter of Einstein clinical programs, such as Healthy Steps and the Infant-Parent Court Affiliated Intervention Project, which help young children and their families in underserved communities in the Bronx obtain critical health services.
About Albert Einstein College of Medicine of Yeshiva University
Albert Einstein College of Medicine of Yeshiva University is one of the nation's premier centers for research, medical education and clinical investigation. During the 2013-2014 academic year, Einstein is home to 734 M.D. students, 236 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 353 postdoctoral research fellows. The College of Medicine has more than 2,000 full-time faculty members located on the main campus and at its clinical affiliates. In 2013, Einstein received more than $155 million in awards from the NIH. This includes the funding of major research centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore Medical Center, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Through its extensive affiliation network involving Montefiore, Jacobi Medical Center–Einstein's founding hospital, and five other hospital systems in the Bronx, Manhattan, Long Island and Brooklyn, Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States. For more information, please visit http://www.einstein.yu.edu and follow us on Twitter @EinsteinMed.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.